The FDA has approved risperidone once-monthly, extended-release injectable suspension for maintenance treatment of bipolar I ...

The FDA has approved Uzedy (risperidone) as monotherapy or as adjunctive therapy to lithium or valproate for the maintenance treatment of bipolar I disorder in adults.

This is a developing news story. Please check back soon for updates. The FDA approved extended-release Uzedy for the ...

Schizoaffective bipolar disorder is a rare mental health condition that displays characteristics of bipolar disorder and ...

Bipolar disorder is a mental health condition characterized by extreme mood swings, including periods of mania (elevated mood ...

Bipolar disorder is genetic, but research suggests that there is both a genetic component and environmental one that ...

Finding stability isn’t always straightforward, and for some, bipolar symptoms remain difficult to manage despite treatment.

Dissociative identity disorder (DID), formerly known as multiple personality disorder, is one of the most intriguing and misunderstood conditions in psychology. Characterized by the presence of two or ...